ArticleWorld journal of urology2023

Durable benefit after treatment of obstructive benign prostatic hyperplasia with a novel drug-device combination product: 2-year outcomes from the EVEREST-I study.

Merycarla Pichardo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.